Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring
Saudi Pharmaceutical Journal · 2026-06 · 34 (3)
DOI: 10.1007/s44446-026-00067-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, online erschienen am 13.05.2026. Verfasst von Mohammad Alsharhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
- Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
- Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia. oalfayez@qu.edu.sa.
Zitieren
APA
Alsharhan, M., Alkhezi, O. S., & Alfayez, O. M. (2026). Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring. Saudi Pharmaceutical Journal, 34(3). https://doi.org/10.1007/s44446-026-00067-1
Vancouver
Alsharhan M, Alkhezi OS, Alfayez OM. Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring. Saudi Pharmaceutical Journal. 2026;34(3). doi:10.1007/s44446-026-00067-1
BibTeX
@article{Alsharhan2026,
author = {Alsharhan, Mohammad and Alkhezi, Omar S and Alfayez, Osamah M},
title = {Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring},
journal = {Saudi Pharmaceutical Journal},
year = {2026},
volume = {34},
number = {3},
doi = {10.1007/s44446-026-00067-1}
}
EUVIMED